Gowling WLG advised Sosei Heptares on a new collaboration with AbbVie to target inflammatory diseases. The collaboration will seek to leverage Sosei Heptares’ unique StaR® technology…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
